Skip to main content
Clinical Trials/ACTRN12617001359325
ACTRN12617001359325
Not yet recruiting
未知

Investigating the effects of the Safe & Sound Protocol (SSP) on frontal alpha asymmetry and motor skills in children aged 8-14 years with Autism.

aTrobe University0 sites68 target enrollmentSeptember 27, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
aTrobe University
Enrollment
68
Status
Not yet recruiting
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 27, 2017
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
aTrobe University

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 1
Investigating the endolift method in the treatment of primary axillary hyperhidrosis
IRCT20200127046282N43Tehran University of Medical Sciences10
Not yet recruiting
Phase 4
euroEPO in mild-moderate Alzheimer's disease amnesic variantmild-moderate Alzheimer's diseaseAlzheimer DiseaseDementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental Disorders
RPCEC00000410Center of Molecular Immunology (CIM)1,456
Completed
Phase 4
Self-administered fentanyl for birthing women.ChildbirthReproductive Health and Childbirth - Childbirth and postnatal care
ACTRN12609000006246Western Health50
Active, not recruiting
Not Applicable
Safety and effectiveness clinical evaluation of the range of injectable medical devices HYDRAGEL C in facial aesthetic treatmentSubjects across groups present with moderate to severe facial aesthetic concerns, including peri-oral lines, nasolabial folds, lip volume deficits, and cheeks/cheekbones volume deficit, as gauged by various dermatological scalesSkin and Connective Tissue Diseases
ISRCTN13586698ouna Aesthetics75
Active, not recruiting
Not Applicable
Clinical study to evaluate the safety and effectiveness of the use of two hyaluronic acid injectable products (Perfectha® Derm Lidocaine and Perfectha® Deep Lidocaine) in the treatment of lipsFor Perfectha® Derm Lidocaine: very thin to thin lip volume and with lip contour somewhat well-defined to poorly definedfor Perfectha® Deep Lidocaine: thin to moderate lip volumeNot Applicable
ISRCTN72858148Sinclair Pharma68